InnoTherapy Inc
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasi… Read more
InnoTherapy Inc (246960) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.004x
Based on the latest financial reports, InnoTherapy Inc (246960) has a cash flow conversion efficiency ratio of -0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-107.41 Million) by net assets (₩24.57 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
InnoTherapy Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how InnoTherapy Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
InnoTherapy Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InnoTherapy Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Superbag Company Limited
PINK:SUPBF
|
N/A |
|
3R Games SA
WAR:3RG
|
0.038x |
|
Cubex Tubings Limited
NSE:CUBEXTUB
|
0.005x |
|
Prasidha Aneka Niaga Tbk
JK:PSDN
|
-0.096x |
|
Intouch Insight Ltd
OTCQX:INXSF
|
0.004x |
|
Cosigo Resources Ltd.
V:CSG
|
0.807x |
|
Altamin Ltd
AU:AZI
|
-0.491x |
|
Tifa Finance Tbk
JK:TIFA
|
-0.031x |
Annual Cash Flow Conversion Efficiency for InnoTherapy Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of InnoTherapy Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩15.52 Billion | ₩-5.96 Billion | -0.384x | -157.47% |
| 2023-12-31 | ₩18.90 Billion | ₩-2.82 Billion | -0.149x | +52.60% |
| 2022-12-31 | ₩13.05 Billion | ₩-4.10 Billion | -0.315x | +20.39% |
| 2021-12-31 | ₩10.08 Billion | ₩-3.98 Billion | -0.395x | -78.14% |
| 2020-12-31 | ₩12.94 Billion | ₩-2.87 Billion | -0.222x | -2.53% |
| 2019-12-31 | ₩15.08 Billion | ₩-3.26 Billion | -0.216x | +5.49% |
| 2018-12-31 | ₩9.52 Billion | ₩-2.18 Billion | -0.229x | +68.62% |
| 2017-12-31 | ₩3.10 Billion | ₩-2.26 Billion | -0.730x | -294.88% |
| 2016-12-31 | ₩6.07 Billion | ₩-1.12 Billion | -0.185x | -200.06% |
| 2015-12-31 | ₩-6.23 Billion | ₩-1.15 Billion | 0.185x | -- |